The causes of reduced GLO1 in skeletal muscle is largely unknown however, we recently described concomitant reductions in GLO1 and NRF2 protein expression, the transcriptional regulator of GLO1 in T2DM subjects (8). Here, GLO1 is linked to type 2 diabetes mellitus.